Medical devices, healthcare technology and the business of care
PMA approval · P910056

SOFLEX UV-ABSORBING SILICONE POSTERIOR CHAMBER INTRAOCULAR LENS

Bausch + Lomb, Inc. · Decision date Jan 17, 1992

FDA DECISIONP910056

What did the FDA approve?

FDA records P910056 as an original PMA application. The recorded decision is approval, dated Jan 17, 1992.

An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.

Regulatory pathway
Original PMA
Clinical specialty
Ophthalmic
Decision date
Jan 17, 1992

FDA source record

Regulatory record facts

Identifier
P910056
Regulatory pathway
Premarket approval application
Product code
HQL
Decision code
APPR
Decision date
Jan 17, 1992
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: intraocular lens.

Product code
HQL
FDA device class
3

FDA decision timeline

  1. P910056 received

    Application receipt date recorded by FDA.

  2. P910056 · FDA decision

    APPR

  3. P910056/S063 · Related supplement

    enVista hydrophobic acrylic intraocular lens

  4. P910056/S065 · Related supplement

    enVista Aspire Hydrophobic Acrylic Intraocular Lens (IOL)

  5. P910056/S064 · Related supplement

    enVista Hydrophobic Acrylic Intraocular Lens

  6. P910056/S066 · Related supplement

    enVista Hydrophobic Acrylic Intraocular Lens

  7. P910056/S067 · Related supplement

    enVista Hydrophobic Acrylic Intraocular Lens

Timeline entries are records held by MedtechLedger for P910056. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P910056

Product / regulatory recordCompanyPathwayDecision dateSource
Bausch + Lomb, Inc.PMA supplementSep 3, 2026FDA
Bausch + Lomb, Inc.PMA supplementSep 29, 2026FDA
Bausch + Lomb, Inc.PMA supplementSep 30, 2026FDA
Bausch + Lomb, Inc.PMA supplementOct 14, 2026FDA
Bausch + Lomb, Inc.PMA supplementOct 23, 2026FDA

Explore the linked device profile

Other records with product code HQL

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Bausch + Lomb, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
50 Technology Dr., Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records